Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

13.49

-0.07 (-0.52%)

Apr 25, 2025, 4:00 PM EDT - Market closed

Viridian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 25, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,100	1,519	1,145	1,176	429	64	Upgrade
Market Cap Growth	32.58%	32.58%	-2.58%	173.76%	568.00%	321.43%	Upgrade
Enterprise Value	406	977	989	892	379	44	Upgrade
Last Close Price	13.50	19.17	21.78	29.21	19.77	16.45	Upgrade
PS Ratio	3642.54	5028.17	3647.53	663.46	144.94	61.23	Upgrade
PB Ratio	2.26	2.26	2.59	2.98	2.29	0.54	Upgrade
P/TBV Ratio	2.28	3.15	4.86	4.65	7.97	-	Upgrade
EV/Sales Ratio	1342.99	3236.51	3150.76	503.65	127.79	41.48	Upgrade
Debt / Equity Ratio	0.03	0.03	0.05	0.01	0.00	0.00	Upgrade
Asset Turnover	0	0	0.00	0.01	0.02	0.01	Upgrade
Quick Ratio	14.99	14.99	17.93	12.73	14.48	11.96	Upgrade
Current Ratio	15.43	15.43	18.27	12.93	14.68	12.14	Upgrade
Return on Equity (ROE)	-48.48%	-48.48%	-56.80%	-44.57%	-51.61%	-163.07%	Upgrade
Return on Assets (ROA)	-30.32%	-30.32%	-34.37%	-26.28%	-29.75%	-31.36%	Upgrade
Return on Capital (ROIC)	-32.26%	-32.26%	-36.80%	-28.52%	-32.28%	-35.04%	Upgrade
Earnings Yield	-18.96%	-17.78%	-20.76%	-11.05%	-18.49%	-172.21%	Upgrade
FCF Yield	-21.17%	-15.33%	-16.16%	-8.05%	-12.79%	-46.39%	Upgrade
Buyback Yield / Dilution	-51.68%	-51.68%	-39.48%	-169.22%	-235.07%	-70.27%	Upgrade

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q